Shelly Hod Moyal is a Founding Partner and Co-CEO at iAngels, and General Partner of the iAngels Ventures Fund, where she invests in Israeli technology companies across Seed, Series A, and Series B stages in Israel and the United States, across sectors including cybersecurity, fintech, insurtech, digital health/healthtech, biotech/life sciences, AI/machine learning, agtech, marketplaces, and SaaS. She serves on the boards of Seed-X, Vyzer, binah.ai, Antidote Health, and Urecsys, and has invested in companies like H2Pro, Guardz, binah.ai, Antidote Health, and Vyzer. Before iAngels, she was an Investment Banker at Goldman Sachs and a Research Analyst at Avenue Capital. Her education includes Northwestern University’s Kellogg School of Management, and she lives in Tel Aviv-Yafo, Israel.
Shelly Hod, Founding Partner @ iAngels. Profile with intro opportunities and ranking information.